Survival and an overview of decision-making in patients with cholangiocarcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 4, 2008, Pages 412-417

  Forsmo, Håvard Mjøorud ^a   Horn, Arild ^a   Viste, Asgaut ^a   Hoem, Dag ^a   Øvrebø, Kjell ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cholangiocarcinoma; Surgery; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGING; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROTOMY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TUMOR LOCALIZATION; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NORWAY; PALLIATIVE CARE; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 49749138503     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-1314.
2. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005;128:620-626.
3. Cancer Registry of Norway. Institute of population-based Research. Cancer in Norway 2004. www.kreftregisteret.no.2004. Ref Type: Journal (Full).
4. Mansfield SD, Barakat O, Charnley RM, Jaques BC, O'Suilleabhain CB, Atherton PJ, et al. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 2005;11: 7625-7630.
5. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394.
6. Gores GJ, Baskin-Bey ES, Baron TH, Alberts SR. Treatment endpoints for advanced cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2004;1:4-5.
7. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224:628-638.
8. Shi QF, Liang TB, Qin YS, Wang WL, Shen Y, Zhang M, et al. Evaluation of surgical approach for extrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6:622-626.
9. Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001;130:584-592.
10. Liu XF, Zhou XT, Zou SQ. An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary Pancreat Dis Int 2005;4:585-588.
11. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004;233:234-240.
12. Rosch T, Meining A, Frühmorgen S, Zillinger C, Schusdziarra V, Hellerhoff K, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002;55:870-876.
13. Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006;239:113-121.
14. Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 2006;11:913-922.
15. Bortolasi L, Burgart LJ, Tsiotos GG, Luque-De León E, Sarr MG. Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection. Dig Surg 2000;17:36-41.
16. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-519.
17. Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hanninen E, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 2003;388:194-200.
18. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003;238:73-83.
19. Yoshida T, Matsumoto T, Sasaki A, Morii Y, Aramaki M, Kitano S. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 2002;137:69-73.
20. Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience. Surgery 2000;127:395-404.
21. Pandey D, Lee KH, Tan KC. The role of liver transplantation for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007;6:248-253.